Abstract
This report analyzes the worldwide markets for Cardiovascular Disease
Diagnostics in Millions of US$. The major product segments analyzed are In
Vitro Diagnostics, and In Vivo Diagnostics. The report provides separate
comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific,
Middle East and Latin America. Annual forecasts are provided for each region
for the period of 2000 through 2015. The report profiles 72 companies
including many key and niche players worldwide such as Abbott Diagnostics,
Biosite, Inc., Cambridge Heart, Inc., Cholestech Corp., Dade Behring, Inc., EP
Medsystems, GE HealthCare, Liposcience, Inc., Philips Medical Systems, Roche
Diagnostics, and Siemens Medical Solutions. Market data and analytics are
derived from primary and secondary research. Company profiles are mostly
extracted from URL research and reported select online sources.
View Cart
